MetaCap

Attovia Therapeutics (ATTO) News

NASDAQ: ATTOHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

15.10-0.48 (-3.08%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ATTO news summary

We found 4 recent headlines mentioning Attovia Therapeutics (ATTO): 0 in the past week and 4 in the past 30 days, most often from GlobeNewswire, Seeking Alpha, Nasdaq. For price context, ATTO is down 3.08% at $15.10. The most recent story, "Attovia Therapeutics, Inc. GAAP EPS of -$0.76", was published by Seeking Alpha on Nov 10, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Attovia Therapeutics headlines

Compare ATTO